Table 3.

Univariate and multivariate analyses of overall survival

		Overall survival
		Univariate		Multivariate (A)		Multivariate (B)
Factor	Category	HR	P	HR	P	HR	P
		95% CI		95% CI		95% CI
Age (years)	<60	1.39	0.348	1.43	0.395
	≥60	0.70–2.77		0.63–3.28
FIGO stage	IB + II	2.91	0.004	4.49	0.001	3.62	0.002
	III + IVA	1.41–6.03		1.91–10.57		1.63–8.02
MTD (mm)	≤40	2.19	0.086	7.59	0.003	6.06	0.003
	>40	0.89–5.36		2.02–28.56		1.88–19.49
PeLN	Negative	1.10	0.793	1.46	0.450
	Positive	0.54–2.22		0.55–3.91
Tumor grade	I + II	1.12	0.752	0.50	0.119
	III	0.55–2.30		0.21–1.20
PD-L1	Negative	1.37	0.670	0.36	0.352
	Positive	0.32–5.90		0.04–3.13
CD8+TILs	Negative	0.41	0.044	0.13	0.003	0.17	0.002
	Positive	0.17–0.98		0.04–0.49		0.06–0.52
Concurrent chemotherapy	No	0.67	0.266	0.32	0.024	0.43	0.043
	Yes	0.33–1.36		0.12–0.86		0.19–0.97

HR = hazard ratio, PeLN = pelvic lymph node metastasis.